ENTRY       D08956                      Drug
NAME        Omacetaxine mepesuccinate (USAN);
            Homoharringtonine;
            Synribo (TN)
PRODUCT     SYNRIBO (Cephalon)
FORMULA     C29H39NO9
EXACT_MASS  545.2625
MOL_WEIGHT  545.6213
SOURCE      Cephalotaxus [TAX:50178]
REMARK      ATC code: L01XX40
            Product: D08956<US>
EFFICACY    Antineoplastic, Protein biosynthesis inhibitor
  DISEASE   Chronic myeloid leukemia [DS:H00004]
TARGET      CCND1 [HSA:595] [KO:K04503]
            MCL1 [HSA:4170] [KO:K02539]
            MYC [HSA:4609] [KO:K04377]
  PATHWAY   hsa04010(4609)  MAPK signaling pathway
            hsa04151(4170+4609+595)  PI3K-Akt signaling pathway
            hsa05200(4609+595)  Pathways in cancer
            hsa05220(4609+595)  Chronic myeloid leukemia
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX40 Omacetaxine mepesuccinate
                  D08956  Omacetaxine mepesuccinate (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antineoplastics, Other
               Omacetaxine Mepesuccinate
                D08956  Omacetaxine mepesuccinate (USAN)
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Signaling molecules
               Transcription factor
                MYC
                 D08956  Omacetaxine mepesuccinate (USAN) &lt;US&gt;
              Cellular process
               Cell cycle
                CCND1
                 D08956  Omacetaxine mepesuccinate (USAN) &lt;US&gt;
               Apoptosis
                MCL1
                 D08956  Omacetaxine mepesuccinate (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D08956
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D08956
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D08956
DBLINKS     CAS: 26833-87-4
            PubChem: 96025639
            ChEBI: 71019
            PDB-CCD: HMT
            LigandBox: D08956
            NIKKAJI: J123.154E
ATOM        39
            1   C8x C    17.6397  -10.6348
            2   C8y C    18.8674  -11.3579
            3   C8y C    16.4129  -11.3276
            4   C8y C    18.8680  -12.7739
            5   C1x C    19.9053  -10.4449
            6   C8y C    16.4136  -12.7437
            7   C1y C    20.0013  -13.6231
            8   C8x C    17.6411  -13.4668
            9   C1x C    21.3216  -10.7589
            10  C1z C    21.3227  -13.2764
            11  C1y C    19.8446  -15.0392
            12  N1y N    21.9515  -12.0173
            13  C2x C    22.0156  -14.5033
            14  C2y C    21.1350  -15.5735
            15  O2a O    21.4189  -16.9266
            16  O2x O    15.0659  -10.8908
            17  C1x C    14.2341  -12.0366
            18  O2x O    15.0672  -13.1819
            19  C1x C    23.5746  -13.6143
            20  C1x C    23.3434  -12.2263
            21  C1x C    22.4975  -14.0511
            22  C1a C    22.7562  -17.3649
            23  O7a O    18.6093  -16.1899
            24  C7a C    18.6093  -17.5899
            25  C1d C    17.4135  -18.2801
            26  O6a O    19.8209  -18.2896
            27  C1b C    16.2093  -17.5846
            28  C7a C    15.0261  -18.2674
            29  O7a O    13.8329  -17.5781
            30  O6a O    15.0258  -19.6698
            31  C1a C    12.6442  -18.2642
            32  C1b C    17.4135  -19.6801
            33  C1b C    16.2178  -20.3704
            34  C1b C    16.2178  -21.7704
            35  C1d C    15.0223  -22.4608
            36  O1a O    13.8099  -23.1608
            37  C1a C    15.7329  -23.6921
            38  C1a C    14.3335  -21.2673
            39  O1a O    18.4034  -19.2700
BOND        43
            1     1   2 1
            2     1   3 2
            3     2   4 2
            4     2   5 1
            5     3   6 1
            6     4   7 1
            7     4   8 1
            8     5   9 1
            9     7  10 1
            10    7  11 1
            11    9  12 1
            12   10  13 1
            13   11  14 1
            14   14  15 1
            15    6   8 2
            16   10  12 1
            17   13  14 2
            18    3  16 1
            19   16  17 1
            20   17  18 1
            21    6  18 1
            22   19  20 1
            23   12  20 1
            24   10  21 1 #Down
            25   21  19 1
            26   15  22 1
            27   11  23 1 #Up
            28   23  24 1
            29   24  25 1
            30   24  26 2
            31   25  27 1
            32   27  28 1
            33   28  29 1
            34   28  30 2
            35   29  31 1
            36   25  32 1
            37   32  33 1
            38   33  34 1
            39   34  35 1
            40   35  36 1
            41   35  37 1
            42   35  38 1
            43   25  39 1 #Down
///
